Omeprazole inhibits natural killer cell functions
- PMID: 17597410
- DOI: 10.1007/s10620-007-9869-2
Omeprazole inhibits natural killer cell functions
Abstract
This study was designed to determine the possible effects of omeprazole on human natural killer cells. Peripheral venous blood samples were taken from 20 peptic ulcer patients before and at the 14th and the 28th days of omeprazole treatment. Mononuclear cells were removed from blood and their capability of making conjugation with K562 target cells and lysing K562 target cells was evaluated. A significant decrease was found (P < 0.001) in the 14th and the 28th days compared with the basal value of the capability of the mononuclear cells to conjugate with the K562 target cells and to lyse them. This study demonstrated that omeprazole significantly reduces natural killer cell functions. This finding suggests that omeprazole may also have some effects on the other systems in addition to parietal cell acid secretion.
Similar articles
-
Fine structural and morphometric studies on gastric parietal cells of peptic ulcer patients after long-term treatment with omeprazole.Arch Histol Cytol. 1998 Oct;61(4):287-95. doi: 10.1679/aohc.61.287. Arch Histol Cytol. 1998. PMID: 9862143
-
Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.Dig Dis Sci. 1996 Oct;41(10):2039-47. doi: 10.1007/BF02093608. Dig Dis Sci. 1996. PMID: 8888719
-
The effect of omeprazole on human natural killer cell activity.Gen Pharmacol. 1995 Oct;26(6):1413-8. doi: 10.1016/0306-3623(94)00301-3. Gen Pharmacol. 1995. PMID: 7590140
-
[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82. Ned Tijdschr Geneeskd. 1985. PMID: 2986019 Review. Dutch. No abstract available.
-
[Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].Pol Tyg Lek. 1985 Dec 23-30;40(51-52):1469-72. Pol Tyg Lek. 1985. PMID: 3008128 Review. Polish. No abstract available.
Cited by
-
Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.Inflammopharmacology. 2018 Apr;26(2):337-347. doi: 10.1007/s10787-017-0380-x. Epub 2017 Jul 22. Inflammopharmacology. 2018. PMID: 28735449 Clinical Trial.
-
Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978. Pharmacoepidemiol Drug Saf. 2010. PMID: 20623507 Free PMC article.
-
Treatment with proton pump inhibitors is associated with secondary bacterial infections and sepsis in patients with COVID-19: a retrospective analysis of their joint impact on in-hospital prognosis.Ann Med. 2024 Dec;56(1):2399761. doi: 10.1080/07853890.2024.2399761. Epub 2024 Oct 30. Ann Med. 2024. PMID: 39475004 Free PMC article.
-
The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice.BMC Res Notes. 2014 Sep 4;7:605. doi: 10.1186/1756-0500-7-605. BMC Res Notes. 2014. PMID: 25190469 Free PMC article.
-
Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.Pharmacol Rep. 2023 Aug;75(4):791-804. doi: 10.1007/s43440-023-00489-x. Epub 2023 May 4. Pharmacol Rep. 2023. PMID: 37142877 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources